Exane Derivatives’s VanEck Russia ETF RSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-77
Closed -$435 1056
2022
Q1
$435 Buy
+77
New +$1.3K ﹤0.01% 882
2021
Q4
Sell
-77
Closed -$2.33K 1108
2021
Q3
$2.33K Hold
77
﹤0.01% 791
2021
Q2
$2.22K Sell
77
-250,661
-100% -$6.88M ﹤0.01% 812
2021
Q1
$6.47M Buy
250,738
+250,551
+133,984% +$6.34M 1.85% 5
2020
Q4
$4.52K Sell
187
-7,992
-98% -$180K ﹤0.01% 565
2020
Q3
$171K Buy
8,179
+3,066
+60% +$67.5K 0.05% 221
2020
Q2
$106K Sell
5,113
-536,483
-99% -$10.6M 0.03% 283
2020
Q1
$9.03M Sell
541,596
-433
-0.1% -$9.67K 2.52% 6
2019
Q4
$14.1M Sell
542,029
-104,743
-16% -$2.54M 2.61% 4
2019
Q3
$14.8M Buy
646,772
+17,041
+3% +$393K 2.65% 5
2019
Q2
$14.9M Sell
629,731
-44,673
-7% -$978K 2.61% 5
2019
Q1
$13.9M Buy
674,404
+27,355
+4% +$563K 2.75% 5
2018
Q4
$12.1M Sell
647,049
-28,859
-4% -$593K 2.18% 7
2018
Q3
$14.6M Sell
675,908
-33,151
-5% -$686K 2.73% 5
2018
Q2
$15.1M Buy
709,059
+666,210
+1,555% +$14.1M 2.51% 7
2018
Q1
$949K Sell
42,849
-745,867
-95% -$17.1M 0.19% 124
2017
Q4
$16.7M Buy
788,716
+772,135
+4,657% +$16.9M 2.88% 9
2017
Q3
$370K Sell
16,581
-3,293
-17% -$68K 0.07% 153
2017
Q2
$381K Sell
19,874
-751,789
-97% -$15M 0.08% 155
2017
Q1
$15.9M Buy
771,663
+21,817
+3% +$459K 3.61% 4
2016
Q4
$15.9M Buy
749,846
+498,662
+199% +$9.67M 3.14% 7
2016
Q3
$4.71M Buy
251,184
+195,094
+348% +$3.57M 0.71% 40
2016
Q2
$977K Sell
56,090
-600,148
-91% -$10.2M 0.16% 90
2016
Q1
$10.7M Buy
656,238
+10,984
+2% +$159K 1.43% 34
2015
Q4
$9.45M Buy
645,254
+531,348
+466% +$8.69M 1.29% 32
2015
Q3
$1.79M Buy
113,906
+19,052
+20% +$314K 0.23% 68
2015
Q2
$1.73M Buy
94,854
+19,504
+26% +$375K 0.19% 68
2015
Q1
$1.28M Sell
75,350
-12,629
-14% -$206K 0.14% 84
2014
Q4
$1.29M Buy
+87,979
New +$1.73M 0.18% 90

Other funds holding RSX

Exane Derivatives's RSX Position: Q2 2022 in Review

Exane Derivatives sold out of VanEck Russia ETF (RSX) in Q2 2022, closing a stake of 77 shares — an estimated $435 sold.

Exane Derivatives first reported a position in RSX in Q4 2014 and held it in 29 quarters. The position peaked at $16.7M in Q4 2017. 117 funds tracked by Wall St. Rank hold RSX as of Q2 2022.

  • Exane Derivatives reported no remaining VanEck Russia ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 77 VanEck Russia ETF shares in Q2 2022, an estimated $435.
  • Exane Derivatives first reported a position in VanEck Russia ETF in Q4 2014 and held it in 29 quarters.
  • Exane Derivatives's VanEck Russia ETF position peaked at $16.7M in Q4 2017.
  • 117 funds tracked by Wall St. Rank held VanEck Russia ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.